GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC_CFI_619/2025, UPC_CFI_150262025, UPC_CFI_2033/2025

GlaxoSmithKline Biologicals SA v. Moderna et al.

Date
2026-02-25
Division
The Hague (NL) Local Division
Type of action
Infringement Action
Language
EN

Metadata

Case IDUPC_CFI_619-2025-UPC_CFI_150262025-UPC_CFI_2033-2025-047de540cd8c
Case number
Registry numberUPC_CFI_619/2025, UPC_CFI_150262025, UPC_CFI_2033/2025
Order reference
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 7

1 The Hague - Local Division UPC_CFI_619/2025 UPC_CFI_1526/2025 UPC_CFI_2033/2025 Order of the Court of First Instance of the Unified Patent Court delivered on 24/02/2026 regarding R.263 and R.9 RoP CLAIMANT 1) GlaxoSmithKline Biologicals SA - Rue de l'Institut 89 - 1330 - Rixensart – BE, “claimant” or “GSK” Represented by Tjibbe Douma and others DEFENDANTS 1) Moderna Netherlands B.V. (Defendant) - Claude Debussylaan 7 - 1082 MC - Amsterdam - NL 2) Moderna Biotech Spain, S.L. (Defendant) - C/Julián Camarillo 31 - 28037 - Madrid - ES 3) Moderna Biotech UK Limited (Defendant) - 54 Portland Place - W1B 1DY - London - GB 2 4) Moderna Biotech Distributor UK Ltd (Defendant) - MYO, 123 Victoria Street - SW1E 6DE - London - GB 5) Moderna Switzerland GmbH (Defendant) - Peter Merian-Weg 10 - 4052 -  ...